Science ❯ Research ❯ Clinical Trials

Drug Efficacy

Vortioxetine Leucovorin Studies GLP-1 Receptor Agonists Phase 1 Trials

FDA Backs Leucovorin for Cerebral Folate Deficiency as White House Promotes Autism Use

Experts warn the authorization applies only to a rare folate disorder rather than autism.